{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:00:34Z","timestamp":1792202434166,"version":"4.4.0"},"reference-count":23,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Sickle cell disease (SCD) in combination with moyamoya syndrome (MMS) represents a rare complication of SCD, with potentially devastating neurological outcomes. The effectiveness of surgical revascularization in this patient population is currently unclear. The authors\u2019 aim was to determine the effectiveness of surgical intervention in their series of SCD-MMS patients by comparing stroke recurrence in those undergoing revascularization and those undergoing conservative transfusion therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The authors performed a retrospective chart review of patients with MMS who were seen at the Johns Hopkins Medical Institution between 1990 and 2013. Pediatric patients (age &lt; 18 years) with confirmed diagnoses of SCD and MMS were included. Intracranial stroke occurrence during the follow-up period was compared between surgically and conservatively managed patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>A total of 15 pediatric SCD-MMS patients (28 affected hemispheres) were included in this study, and all were African American. Seven patients (12 hemispheres) were treated with indirect surgical revascularization. The average age at MMS diagnosis was 9.0 \u00b1 4.0 years, and 9 patients (60.0%) were female. Fourteen patients (93.3%) had strokes before diagnosis of MMS, with an average age at first stroke of 6.6 \u00b1 3.9 years. During an average follow-up period of 11.6 years, 4 patients in the conservative treatment group experienced strokes in 5 hemispheres, whereas no patient undergoing the revascularization procedure had any strokes at follow-up (p = 0.029). Three patients experienced immediate postoperative transient ischemic attacks, but all recovered without subsequent strokes.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Indirect revascularization is suggested as a safe and effective alternative to the best medical therapy alone in patients with SCD-MMS. High-risk patients managed on a regimen of chronic transfusion should be considered for indirect revascularization to maximize the effect of stroke prevention.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2017.1.peds16576","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T14:02:01Z","timestamp":1499436121000},"page":"232-238","source":"Crossref","is-referenced-by-count":29,"title":["Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome"],"prefix":"10.3171","volume":"20","author":[{"given":"Wuyang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Porras","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford M.","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Khalid","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Garzon-Muvdi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Caplan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey P.","family":"Colby","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Coon","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael J.","family":"Tamargo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams RJ","year":"2005","unstructured":"Adams RJ, Brambilla D: Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 353:2769\u20132778, 200510.1056\/NEJMoa05046016382063"},{"key":"b2","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams RJ","year":"1998","unstructured":"Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, : Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339:5\u201311, 1998964787310.1056\/NEJM199807023390102"},{"key":"b3","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000120932","article-title":"Pial synangiosis for moyamoya syndrome in children","volume":"23","author":"Adelson PD","year":"1995","unstructured":"Adelson PD, Scott RM: Pial synangiosis for moyamoya syndrome in children. Pediatr Neurosurg 23:26\u201333, 1995749566310.1159\/000120932"},{"key":"b4","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun MR","year":"2014","unstructured":"DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, : Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med 371:699\u2013710, 20142514095610.1056\/NEJMoa1401731"},{"key":"b5","series-title":"Blood","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1182\/blood-2015-09-618579","article-title":"Central nervous system complications and management in sickle cell disease: a review","volume":"127","author":"DeBaun MR","year":"2016","unstructured":"DeBaun MR, Kirkham FJ: Central nervous system complications and management in sickle cell disease: a review. Blood 127:829\u2013838, 20162675891710.1182\/blood-2015-09-618579"},{"key":"b6","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(15)01130-7","article-title":"New option for primary stroke prevention in sickle cell anaemia","volume":"387","author":"DeBaun MR","year":"2016","unstructured":"DeBaun MR, Kirkham FJ: New option for primary stroke prevention in sickle cell anaemia. Lancet 387:626\u2013627, 20162667061810.1016\/S0140-6736(15)01130-7"},{"key":"b7","series-title":"Blood","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1182\/blood.V99.9.3144","article-title":"Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events","volume":"99","author":"Dobson SR","year":"2002","unstructured":"Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, : Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 99:3144\u20133150, 200210.1182\/blood.V99.9.314411964276"},{"key":"b8","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1212\/01.WNL.0000078894.79866.95","article-title":"Risk of stroke in children: ethnic and gender disparities","volume":"61","author":"Fullerton HJ","year":"2003","unstructured":"Fullerton HJ, Wu YW, Zhao S, Johnston SC: Risk of stroke in children: ethnic and gender disparities. Neurology 61:189\u2013194, 20031287439710.1212\/01.WNL.0000078894.79866.95"},{"key":"b9","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3171\/2014.12.PEDS14522","article-title":"Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease","volume":"16","author":"Griessenauer CJ","year":"2015","unstructured":"Griessenauer CJ, Lebensburger JD, Chua MH, Fisher WS III, Hilliard L, Bemrich-Stolz CJ, : Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease. J Neurosurg Pediatr 16:64\u201373, 20152583788610.3171\/2014.12.PEDS14522"},{"key":"b10","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3171\/PED\/2008\/1\/3\/211","article-title":"Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis","volume":"1","author":"Hankinson TC","year":"2008","unstructured":"Hankinson TC, Bohman LE, Heyer G, Licursi M, Ghatan S, Feldstein NA, : Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. J Neurosurg Pediatr 1:211\u2013216, 20081835276510.3171\/PED\/2008\/1\/3\/211"},{"issue":"1","key":"b11","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2013.10.FOCUS13405","article-title":"Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases","volume":"36","author":"Kennedy BC","year":"2014","unstructured":"Kennedy BC, McDowell MM, Yang PH, Wilson CM, Li S, Hankinson TC, : Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases. Neurosurg Focus 36(1):E12, 201410.3171\/2013.10.FOCUS1340524380478"},{"key":"b12","series-title":"Blood","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1182\/blood-2005-10-009506","article-title":"Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results","volume":"108","author":"Lee MT","year":"2006","unstructured":"Lee MT, Piomelli S, Granger S, Miller ST, Harkness S, Brambilla DJ, : Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood 108:847\u2013852, 200610.1182\/blood-2005-10-00950616861341"},{"key":"b13","article-title":"Evidence-Based Management of Sickle Cell Disease. Expert Panel Report, 2014","year":"2014","unstructured":"National Heart, Lung, and Blood Institute: Evidence-Based Management of Sickle Cell Disease. Expert Panel Report, 2014. Washington, DC: National Institutes of Health, 2014 (https:\/\/www.nhlbi.nih.gov\/sites\/www.nhlbi.nih.gov\/files\/sickle-cell-disease-report%20020816.pdf) [Accessed June 19, 2017]"},{"key":"b14","series-title":"J Pediatr","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow CH","year":"1995","unstructured":"Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, : Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 126:896\u2013899, 1995777609110.1016\/S0022-3476(95)70204-0"},{"key":"b15","series-title":"Am J Med","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The natural history of stroke in sickle cell disease","volume":"65","author":"Powars D","year":"1978","unstructured":"Powars D, Wilson B, Imbus C, Pegelow C, Allen J: The natural history of stroke in sickle cell disease. Am J Med 65:461\u2013471, 197810.1016\/0002-9343(78)90772-6717414"},{"key":"b16","series-title":"Blood","first-page":"162","article-title":"Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease","volume":"63","author":"Russell MO","year":"1984","unstructured":"Russell MO, Goldberg HI, Hodson A, Kim HC, Halus J, Reivich M, : Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 63:162\u2013169, 19846689947"},{"issue":"2 Suppl Pediatrics","key":"b17","series-title":"J Neurosurg","first-page":"142","article-title":"Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis","volume":"100","author":"Scott RM","year":"2004","unstructured":"Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100 (2 Suppl Pediatrics):142\u2013149, 200414758941"},{"issue":"4","key":"b18","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2009.01.FOCUS08307","article-title":"Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome","volume":"26","author":"Smith ER","year":"2009","unstructured":"Smith ER, McClain CD, Heeney M, Scott RM: Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus 26(4):E10, 20091933512610.3171\/2009.01.FOCUS08307"},{"key":"b19","series-title":"Blood","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1182\/blood-2009-05-220921","article-title":"Sickle cell disease and stroke","volume":"114","author":"Verduzco LA","year":"2009","unstructured":"Verduzco LA, Nathan DG: Sickle cell disease and stroke. Blood 114:5117\u20135125, 20091979752310.1182\/blood-2009-05-220921"},{"key":"b20","series-title":"Pediatrics","first-page":"484","article-title":"Quality-of-care indicators for children with sickle cell disease","volume":"128","author":"Wang CJ","year":"2011","unstructured":"Wang CJ, Kavanagh PL, Little AA, Holliman JB, Sprinz PG: Quality-of-care indicators for children with sickle cell disease. Pediatrics 128:484\u2013493, 201121844055"},{"key":"b21","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial Doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware RE","year":"2016","unstructured":"Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, : Hydroxycarbamide versus chronic transfusion for maintenance of transcranial Doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet 387:661\u2013670, 20162667061710.1016\/S0140-6736(15)01041-7"},{"key":"b22","series-title":"Blood","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)","volume":"119","author":"Ware RE","year":"2012","unstructured":"Ware RE, Helms RW: Stroke With Transfusions Changing to Hydroxyurea (SWiTCH). Blood 119:3925\u20133932, 20122231819910.1182\/blood-2011-11-392340"},{"key":"b23","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn BP","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, : Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312:1033\u20131048, 201410.1001\/jama.2014.10517"}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/20\/3\/article-p232.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/20\/3\/article-p232.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/20\/3\/article-p232.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T13:53:04Z","timestamp":1681566784000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/20\/3\/article-p232.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":23,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2017.1.peds16576","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}